Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-475
Closed -$29.3K – 932
2021
Q3
$29.3K Hold
475
– – ﹤0.01% 695
2021
Q2
$28.4K Hold
475
– – ﹤0.01% 726
2021
Q1
$28.9K Hold
475
– – ﹤0.01% 675
2020
Q4
$22.3K Hold
475
– – ﹤0.01% 688
2020
Q3
$17.7K Hold
475
– – ﹤0.01% 668
2020
Q2
$17.3K Hold
475
– – ﹤0.01% 652
2020
Q1
$14.5K Hold
475
– – ﹤0.01% 614
2019
Q4
$24.2K Hold
475
– – ﹤0.01% 609
2019
Q3
$22.4K Hold
475
– – ﹤0.01% 610
2019
Q2
$23.6K Hold
475
– – ﹤0.01% 615
2019
Q1
$20.2K Hold
475
– – ﹤0.01% 646
2018
Q4
$19.5K Hold
475
– – ﹤0.01% 632
2018
Q3
$22.2K Hold
475
– – ﹤0.01% 661
2018
Q2
$20.7K Hold
475
– – ﹤0.01% 670
2018
Q1
$21.8K Hold
475
– – ﹤0.01% 656
2017
Q4
$24K Hold
475
– – ﹤0.01% 636
2017
Q3
$24.7K Buy
+475
New +$23.1K ﹤0.01% 638

Other funds holding MET

RBC Europe's MET Position: Q4 2021 in Review

RBC Europe sold out of MetLife (MET) in Q4 2021, closing a stake of 475 shares — an estimated $29.3K sold.

RBC Europe first reported a position in MET in Q3 2017 and held it in 17 quarters. The position peaked at $29.3K in Q3 2021. 1,192 funds tracked by Wall St. Rank hold MET as of Q4 2021.

  • RBC Europe reported no remaining MetLife position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 475 MetLife shares in Q4 2021, an estimated $29.3K.
  • RBC Europe first reported a position in MetLife in Q3 2017 and held it in 17 quarters.
  • RBC Europe's MetLife position peaked at $29.3K in Q3 2021.
  • 1,192 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.